Wall Street analysts expect Dolby Laboratories, Inc. (NYSE:DLB) to announce $0.64 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Dolby Laboratories’ earnings. The lowest EPS estimate is $0.63 and the highest is $0.66. Dolby Laboratories reported earnings of $0.63 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 1.6%. The company is expected to issue its next quarterly earnings report on Wednesday, April 25th.
On average, analysts expect that Dolby Laboratories will report full-year earnings of $0.99 per share for the current financial year, with EPS estimates ranging from $0.79 to $1.15. For the next financial year, analysts forecast that the business will post earnings of $2.74 per share, with EPS estimates ranging from $2.58 to $2.87. Zacks’ earnings per share averages are an average based on a survey of analysts that cover Dolby Laboratories.
Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Wednesday, January 24th. The electronics maker reported $0.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.44 by $0.35. The firm had revenue of $287.80 million during the quarter, compared to analyst estimates of $265.75 million. Dolby Laboratories had a return on equity of 12.02% and a net margin of 6.06%. Dolby Laboratories’s quarterly revenue was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.66 earnings per share.
Shares of Dolby Laboratories (DLB) opened at $67.07 on Tuesday. The stock has a market capitalization of $6,841.90, a P/E ratio of 106.46, a P/E/G ratio of 5.56 and a beta of 0.75. Dolby Laboratories has a twelve month low of $48.00 and a twelve month high of $74.29.
The company also recently announced a quarterly dividend, which was paid on Wednesday, February 14th. Investors of record on Monday, February 5th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.95%. The ex-dividend date was Friday, February 2nd. Dolby Laboratories’s payout ratio is 101.59%.
In other Dolby Laboratories news, Director N William Jasper, Jr. sold 20,000 shares of the stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $66.72, for a total transaction of $1,334,400.00. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Giles Baker sold 35,866 shares of the stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $64.08, for a total value of $2,298,293.28. The disclosure for this sale can be found here. Over the last three months, insiders sold 532,134 shares of company stock worth $33,369,380. 43.74% of the stock is owned by insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. BlackRock Inc. grew its position in Dolby Laboratories by 0.8% during the 4th quarter. BlackRock Inc. now owns 3,092,122 shares of the electronics maker’s stock worth $191,712,000 after purchasing an additional 25,262 shares during the period. Janus Henderson Group PLC grew its position in Dolby Laboratories by 352.2% during the 3rd quarter. Janus Henderson Group PLC now owns 2,657,618 shares of the electronics maker’s stock worth $152,875,000 after purchasing an additional 2,069,849 shares during the period. TimesSquare Capital Management LLC grew its position in Dolby Laboratories by 6.9% during the 3rd quarter. TimesSquare Capital Management LLC now owns 1,795,000 shares of the electronics maker’s stock worth $103,248,000 after purchasing an additional 116,500 shares during the period. Timucuan Asset Management Inc. FL grew its position in Dolby Laboratories by 0.7% during the 4th quarter. Timucuan Asset Management Inc. FL now owns 1,221,424 shares of the electronics maker’s stock worth $75,728,000 after purchasing an additional 8,110 shares during the period. Finally, Thrivent Financial For Lutherans grew its position in Dolby Laboratories by 2.2% during the 4th quarter. Thrivent Financial For Lutherans now owns 947,150 shares of the electronics maker’s stock worth $58,723,000 after purchasing an additional 20,610 shares during the period. 53.28% of the stock is currently owned by institutional investors.
About Dolby Laboratories
Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.